A significant advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial tumor protector protein is frequently disabled in many kinds of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research